High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma.

Saved in:
Bibliographic Details
Title: High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma.
Authors: Daneels, Willem1,2,3,4 (AUTHOR) willem.daneels@ugent.be, Van Parys, Alexander4,5,6 (AUTHOR), Huyghe, Leander4,5,6 (AUTHOR), Rogge, Elke4,5,6 (AUTHOR), De Rouck, Steffi4,5,6 (AUTHOR), Christiaen, Ruben6 (AUTHOR), Zabeau, Lennart6 (AUTHOR), Taveirne, Sylvie6 (AUTHOR), Van Dorpe, Jo3,7,8 (AUTHOR), Kley, Niko6 (AUTHOR), Cauwels, Anje3,4,5,6 (AUTHOR), Depla, Erik6 (AUTHOR), Tavernier, Jan3,4,5,6 (AUTHOR), Offner, Fritz1,2,3 (AUTHOR)
Source: Experimental Hematology & Oncology. 6/3/2024, Vol. 13 Issue 1, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21623619
DOI:10.1186/s40164-024-00524-4